To evaluate the contribution of the major histocompatibility complex class I pockets to the binding of self-peptides recognized by alloreactive cytotoxic T-lymphocyte (CTL) clones, we have constructed an extensive library of HLA-A2 mutants with different amino acid substitutions in each of the six pockets. When these mutants were tested in cytotoxicity assays with a panel ofHLA-A2-specific afloreactive CTL clones, each CTL clone showed a unique pattern of reactivity, implying the different contributions of each pocket to binding individual peptides. We noted that the majority of the mutants in pocket B significantly affect recognition by the CTL clones. Unexpectedly, the mutations influencing allorecognition are found in all other pockets as well. Overall, this study demonstrates that each ofthe six peptide-binding pockets plays an important and distinct role in binding of self-peptides required for recognition of the HLA-A2 molecule by alloreactive CTLs.
cytotoxicity assays with a panel ofHLA-A2-specific afloreactive CTL clones, each CTL clone showed a unique pattern of reactivity, implying the different contributions of each pocket to binding individual peptides. We noted that the majority of the mutants in pocket B significantly affect recognition by the CTL clones. Unexpectedly, the mutations influencing allorecognition are found in all other pockets as well. Overall, this study demonstrates that each ofthe six peptide-binding pockets plays an important and distinct role in binding of self-peptides required for recognition of the HLA-A2 molecule by alloreactive CTLs.
Class I major histocompatibility complex molecules are essential for target-cell recognition by alloreactive and antigenspecific cytotoxic T lymphocytes (CTLs). These molecules are transported to and expressed on the cell surface as a trimeric complex composed ofa polymorphic heavy chain, an invariant 82-microglobulin, and a peptide (1) (2) (3) . The crystal structure of the class I protein HLA-A2 (A2) reveals the presence of an extra electron density, presumably peptides, in a groove formed by two a-helices of the al and a2 domains, which lie across an eight-stranded l-pleated sheet floor (4, 5) . More recently, a higher resolution analysis of the A2 structure shows six pockets or subsites, designated pocket A-F, within the groove (6) . Similar structures are also seen in HLA-Aw68 (7), HLA-B27 (8) , and H-2Kb (9) . These pockets contain many of the residues that are polymorphic among the class I molecules and are proposed to determine the specificity of peptide interaction.
Sequence analyses of self-peptides purified from different class I molecules show allele-specific motifs with predominant amino acids at fixed positions (10, 11) . This implies that peptide binding to the class I molecule is governed by anchor residues interacting with specific pockets. In the case of A2-associated peptides, leucine or methionine, commonly found at position 2, is postulated to fit into pocket B. Previous studies have used mutant class I molecules to evaluate the role of these pockets in CTL recognition. However, most studies tested mutants targeted primarily to pocket B (12) (13) (14) (15) , and others examined recognition of peptide-pulsed targets by virus-specific CTL (16) (17) (18) (19) . Our study focuses on the contribution of each peptide-binding pocket to alloreactive CTL recognition. We have constructed an extensive library of A2 mutants with different amino acid substitutions in each of the six pockets and examined whether these changes affect the binding of self-peptides as detected by a panel of alloreactive CTL clones. In contrast to expectation, this study demonstrates that all six pockets appear to play important but unique roles in allorecognition of the A2 molecule.
MATERIALS AND METHODS
Construction of Mutant A2 Genes and Their Expression in HMy2.ClR Cells. Thirty-three mutant A2 genes with single substitutions in the six peptide-binding pockets of the A2 molecule were constructed by a combination of site-directed and saturation mutagenesis as described (20, 21) . Each of the mutant genes (listed in Table 1 ) is designated with the single-letter code of the original amino acid residue, followed by the number of the position and the code of the changed amino acid. The mutant A2 genes were cotransfected with pSV2-neo into the HLA-A-null human B-lymphoid cell line HMy2.ClR (C1R) (22) by electroporation. After selection with Geneticin (G418), the transfectants were analyzed for their surface A2 expression by flow cytometry (EPICS 7-52) using indirect immunofluorescence with monoclonal antibodies MA2.1 (23) and BB7.2 (24) . Most 5iCr-Release Cytotoxicity Assay. The CTL clones were tested for recognition of the mutant A2 molecules in the standard 5tCr-release assay (26) . In each experiment, C1R cells transfected with the wild-type A2 gene (C1R-A2) and pSV2-neo gene (ClR-neo) were used as positive and negative controls, respectively. Specific lysis was calculated as follows: % specific lysis = [(cpmsample -cpmspontaneous)/ Abbreviations: CTL, cytotoxic T lymphocyte; MFI, mean logarithm of the fluorescence intensity; E/T, effector to target. *To whom reprint requests should be addressed.
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*The pockets in which the amino acid substitutions are located. tSurface expression of the A2 mutants on transfected C1R cells was detected by indirect immunofluorescence and calculated relative to that of the wild-type molecule.
(Cpmaximum -cpmsPontanOus)] x 100. Spontaneous release represents the radioactivity released by target cells in the absence of effectors, and maximum release represents the radioactivity released by target cells lysed with 5% Triton X-100.
To allow comparison among different experiments, the results were standardized as percent relative lysis by the following formula: % relative lysis = [(% specific lysis of ClRmutant A2 -% specific lysis of C1Rnem)/(% specific lysis of ClRwlddtype A2 -% specific lysis of ClRne)] x 100.
RESULTS
Generation of A2-Specific CTL Clones. An A2-reactive human CTL line was generated from a healthy A2-negative donor by weekly in vitro stimulation with wild-type A2-transfected C1R (C1R-A2) cells in the presence of interleukin 2. From this line, eight different clones were isolated by limiting dilution. These clones were tested for their A2 specificity in the standard 51Cr release assay using C1R-A2 and ClR-neo cells as targets. Fig. 1 shows the cytotoxicity of two representative clones, DQ-2 and DQ-3, against C1R-A2 and C1R-neo cells at effector to target (E/T) ratios of 0.1-10.
All of the clones lyse the C1R-A2 cells, but fail to kill C1R target cells not expressing A2. These results demonstrate the specificity of the CTL clones for the A2 molecule.
To establish peptide specificity of the CTL clones, we tested the clones for recognition of the peptide-transporterdeficient cell line T2, which expresses a limited repertoire of A2-bound self-peptides (27) . None of the clones tested here killed T2 cells, although other CTL clones not used in this study did (data not shown). This suggests that allorecognition of the A2 molecule by the CTL clones is peptide-dependent.
Ailoreactive CTL Recognition of Mutant A2 Molecules with Single Substitutions in the Peptide-Binding Pockets. Eight CTL clones were tested for reactivity against C1R cells expressing the mutant A2 molecules. Fig. 2 shows cytotoxic activities of the DQ-2 and DQ-3 clones against pocket C mutants an example of the data obtained. The results from all mutant and CTL clones are summarized and presented as percent rel tive lysis in Fig. 3 . Each of the CTL clones shows a distinct p ttern of reactivity. Some of the clones, particularly DQ-2 and DQ-15, are highly sensitive to many mutations in all of the ckets. In contrast, the DQ-3 and DQ-64 clones are tolerant of most of the mutations. Overall, the data demonstrate that each clone exhibits a different pattern of mutant recognition, suggesting its unique specificity in recognizing the A2 molecule. This result is consistent with the theory that each of the clones may recognize a different self-peptide bound to the A2 molecule.
Because of the striking predominance of leucine and methionine at position 2 of A2-associated self-peptides (10, 11), we had expected that alteration of residues in pocket B would easily be detected by the loss of CTL recognition, whereas mutations in other pockets would be less likely to have widespread effects on all clones. Indeed, we found that mutations in pocket B have a strong impact on recognition of alloreactive CTL. Surprisingly, the majority of the mutations in the other pockets also affect CTL recognition of the A2 molecule. Out of the 33 mutants tested, 29 reduce or abolish the recognition of at least one of the clones (relative lysis < 50%). One mutation (V152E in pocket E) completely abrogates the recognition of all eight clones (relative lysis < 20%o).
When the effect of mutations in the different pockets are compared, those in pockets A [67%; 48 altered recognition out of 72 tested (48/72)], B (48%; 46/96), C (66%; 21/32), D (46%; 26/56), and E (60%; 24/40) have strong impact on most clones, whereas pocket F mutations appear to have the least effect (36%; 20/56). This difference is statistically significant when the pocket F data are compared to the pooled data of pockets A-E (P < 0.004). However, comparisons between data of individual pockets show either not significant or barely significant differences (Table 2) . Overall, the results show that the mutations affecting allorecognition are not limited to pocket B; rather, they are distributed among all six pockets. Thus, each of the six pockets has a critical role in binding self-peptides.
A number of mutations involve residues (7, 9, 66, 97, 99, 114, 147, and 156) of which side chains constitute more than one peptide-binding pocket and appear to have detrimental effects on many clones. However, when the data for these mutants were compared to those of mutants involving single pockets, we detected no significant difference. Mutations residing within a single pocket, such as positions 167 and 171 (pocket A), 73 (pocket C), 155 (pocket D), 152 (pocket E), and 146 (pocket F), also have a strong impact on many of the clones. Again, we noted that these mutations are not clustered to any one pocket. Unexpectedly, we observed that significant changes at certain invariant residues can be well tolerated by the CTL clones. This is exemplified by the V25D substitution, which has a minimal effect on all of the eight clones. In contrast to this, a relatively conservative change, phenylalanine to tyrosine at the polymorphic residue 9, drastically reduced the recognition of many of the clones.
DISCUSSION
To assess the importance of peptide-binding pockets in allorecognition, we have tested a library of A2 mutants with amino acid changes in each of the six pockets. With the exception of mutations at position 113, all of the mutations tested here involve residues whose side chains are postulated to contact peptides bound in the groove and not T-cell receptors (6) . We speculate that these mutations alter the affinity of the A2 molecules for peptides, resulting in presentation of different peptide repertoires and subsequent loss of CTL recognition. It seems unlikely that the overall A2 structure is affected drastically by the mutations and/or the binding of different peptides. In support of this, we observed no difference in the relative binding of conformationsensitive monoclonal antibodies to the mutant A2 molecules (data not shown). Furthermore, a recent crystallographic study shows that the overall structures of the A2 and murine H-2Kb molecules share a high degree of similarity, even though they bind different sets of peptides and differ in sequence by 30%6 (9) .
Alternatively, the mutations may change the conformation of the peptide-class I complex so that some T-cell receptors (9) . Thus, it is possible that the pocket mutations also have subtle effects on the structure, which can be discriminated by the CTL clones without altering the peptides bound. Since leucine or methionine at position 2 of A2-associated peptides is believed to be the anchor residue interacting with pocket B (10, 11), we anticipated that mutations in this pocket would have a strong effect on allorecognition. We were gratified to note that -50o of the tested pocket B mutants significantly reduced or abolished allorecognition. These results are in accord with those of previous work on both A2 (12, 13) and B27 alleles (14, 15) . However, we observed that alterations in other pockets (except F) produce an impact on recognition equivalent to that of the pocket B mutations. If this is a general case, it has important implications on the nature of peptides recognized by alloreactive T cells. ets. These clones were tested in the standard 51Cr release assay at an E/T of 1:1. The results are compared to the specific lysis of wild-type A2-expressing COR cells and reported here as percent relative lysis.
The eight CTL clones analyzed in this study were selected on the basis of their growth properties and not on their specificity. All of the clones kill C1R cells expressing the wild-type A2 molecule, but each shows a distinctive recognition pattern of the mutant A2 molecules. These results suggest that each of the clones represents an alloreactive CTL recognizing the A2 molecule with a unique specificity. We also observed that none of the CTL clones recognizes peptide-transporter-defective T2 cells, which bear very few A2-associated self-peptides (27) . Taken together, these findings are consistent with the theory that the distinct specificity of the clones in allorecognition may be determined by different self-peptides bound to the A2 molecule.
Sequence analysis of self-peptides isolated from A2 molecules revealed that A2-associated peptides are 9 amino acids long with an allele-specific motif consisting of leucine or methionine at position 2 and valine or leucine at position 9 (10, 11). These residues are suggested to serve as anchor positions directly interacting with the peptide-binding pock- (28) . To deal with the problem of multiple comparisons, the P value was multiplied by the number of tests performed. The same statistical analyses were done on all mutations pooled and on those affecting only single pockets, and there was no difference in the values obtained from the two analyses. NS, not significant (P > 0.05).
ets: position 2 fits into pocket B, while position 9 occupies pocket F. Thus, such peptides would have been affected most by changes in these pockets. In accordance with this, Winter et al. (13) reported the significant effect of mutations within pocket B on CTL recognition of an A2-restricted influenza virus matrix peptide. Unexpectedly, our results show that the mutations altering allorecognition are not limited to a particular pocket. If these data represent CTL recognition of self-peptides in general, we speculate that the self-peptides recognized by alloreactive CTLs may not be characterized by the known allele-specific motifs and may constitute a relatively minor fraction of the total self-peptides bound to class I molecules.
Using an extensive library of A2 mutants, we have demonstrated that all six peptide-binding pockets of the A2 molecule play a role in allorecognition. Mutations that can influence recognition by alloreactive CTL clones are found not only in pocket B but also in other pockets.
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